Valuation: Omnicell, Inc.

Market Cap 1.48B 1.29B 1.21B 1.11B 2.07B 142B 2.08B 14.55B 5.61B 72.19B 5.56B 5.43B 233B P/E 2026 *
33x
P/E 2027 * 32x
Enterprise Value 1.48B 1.29B 1.21B 1.11B 2.07B 142B 2.08B 14.55B 5.61B 72.19B 5.56B 5.43B 233B EV / Sales 2026 *
1.2x
EV / Sales 2027 * 1.15x
Free-Float
76.4%
Yield 2026 *
-
Yield 2027 * -
1 day+1.26%
1 week+0.92%
Current month-6.34%
1 month-4.99%
3 months-14.87%
6 months-4.02%
Current year-27.31%
1 week 31.98
Extreme 31.975
33.22
1 month 31.98
Extreme 31.975
35.66
Current year 31.75
Extreme 31.75
55
1 year 29.06
Extreme 29.06
55
3 years 22.66
Extreme 22.66
55.74
5 years 22.66
Extreme 22.66
187.28
10 years 22.66
Extreme 22.66
187.28
Manager TitleAgeSince
Chief Executive Officer 68 01/10/2002
Director of Finance/CFO 56 15/09/2025
President 50 01/07/2026
Director TitleAgeSince
Chairman 68 01/09/1992
Director/Board Member 70 01/01/2013
Director/Board Member 70 01/01/2014
Date Insider Type Main position Quantity % Market Cap. Importance
17/8/26 Sell

Chairperson

-3,083 0.0068%
15/8/26 Tax

Chief Executive Officer

-12,350 0.0272%
15/8/26 Tax

Chief Administrative Officer

-4,025 0.0089%
Change 5-day change 1-year change 3-year change Capi.($)
+1.26%+0.92%+4.14%-33.90% 1.48B
+0.07%-2.26%-7.30%+28.29% 42.31B
-0.75%-0.65%-47.55%+127.07% 12.32B
-1.06%-5.47%-11.56%+106.64% 5.54B
+0.02%+3.77%+59.56% - 4.38B
+1.84%+9.33% - - 2.23B
-2.25%+0.97%-36.01% - 1.06B
+0.30%-0.89%+13.21%+159.84% 989M
-0.99%+2.76%+39.03%+53.12% 905M
+3.49%+4.71%-28.51%-44.63% 796M
Average +0.21%+1.43%-1.67%+56.63% 7.2B
Weighted average by Cap. -0.07%-0.78%-10.10%+53.99%

Financials

2026 *2027 *
Net sales 1.24B 1.08B 1.02B 925M 1.73B 119B 1.74B 12.16B 4.69B 60.36B 4.65B 4.54B 195B 1.29B 1.12B 1.06B 963M 1.81B 123B 1.81B 12.67B 4.88B 62.87B 4.84B 4.73B 203B
Net income 45.27M 39.47M 37.18M 33.86M 63.48M 4.34B 63.56M 445M 172M 2.21B 170M 166M 7.13B 47.37M 41.3M 38.9M 35.42M 66.42M 4.54B 66.5M 466M 180M 2.31B 178M 174M 7.46B
Net Debt - -
Logo Omnicell, Inc.
Omnicell, Inc. is a healthcare technology provider focused on autonomous medication management, by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities. The Company is focused on helping its customers define and deliver a medication management strategy designed for pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. It provides a range of points of care medication and supplies dispensing systems, including automated systems and offers advanced automation solutions, including robotics designed to automate work, streamline workflows, and reduce human error. It provides central pharmacy automation solutions for both medication dispensing and IV compounding and provides patient engagement solutions.
Employees
3,485
Date Price Change Volume
22/09/26 US$32.93 +1.54% 61,165
21/09/26 US$32.43 +0.62% 434,860
18/09/26 US$32.23 -1.20% 937,250
17/09/26 US$32.62 +0.59% 394,292
16/09/26 US$32.43 -0.61% 439,351
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
32.43USD
Average target price
57.86USD
Spread / Average Target
+78.41%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OMCL Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!